Chlorothiazide for edema & hypertension - Drug information

Chlorothiazide inhibits sodium and water reabsorption in the distal tubules resulting in salt and water loss from the body. It is thus used to treat the following conditions:

  • Edematous and fluid overloaded states
  • It may be used to treat Hypertension as monotherapy (or in combination with other medicines ) in the absence of other comorbid conditions like diabetes, kidney disease, ischemic heart disease, and cerebrovascular disease.

Chlorothiazide Dose in Adults

  • Dose in Hypertension:
    • 500 to 2,000 mg per day once or twice daily.

  • Dose in patients with Edema:
    • 250 to 500 mg orally once or twice daily to a maximum daily dose of 1,000 mg.
    • 500 to 1,000 mg intravenous once a day in combination with a loop diuretic

Chlorothiazide Dose in Childrens

  • For diuresis, heart failure, and hypertension:
    • Infants, Children, and Adolescents:

  • Dose in central Diabetes insipidus:

Pregnancy Risk Factor C

  • The placental barrier is crossed by chlorothiazide and can cause neonatal jaundice or thrombocytopenia.
  • Women with hypertension may need thiazide diuretics during pregnancy. It should not be used to treat edema caused by pregnancy

Chlorothiazide use during breastfeeding:

  • Breastmilk contains chlorothiazide, which can be excreted in this substance.
  • This could lead to serious adverse drug reactions in the child.
  • You should stop using it while you are breastfeeding. 
  • Nursing mothers should avoid diuretics as they can reduce milk production.

Chlorothiazide Dose in Kidney Disease:

  • It is usually not effective in patients with a CrCl of less than 30 mL/minute and is, therefore, combined with a loop diuretic.
  • Patients with a CrCl of less the 10 mL/minute should avoid the drug.

Chlorothiazide Dose in Liver Disease:

The manufacturer has not recommended any dose adjustment in patients with liver disease, however, it should be used with caution in advanced liver disease.

Side Effects of Chlorothiazide:

  • Cardiovascular:
    • Hypotension
    • Necrotizing angiitis
    • Orthostatic hypotension
  • Central nervous system:
    • Dizziness
    • Headache
    • Paresthesia
    • Restlessness
    • Vertigo
  • Dermatologic:
    • Alopecia
    • Erythema multiforme
    • Exfoliative dermatitis
    • Skin photosensitivity
    • Skin rash
    • Stevens-Johnson syndrome
    • Toxic epidermal necrolysis
    • Urticaria
  • Endocrine & metabolic:
    • Glycosuria
    • Hypercalcemia
    • Hyperglycemia
    • Hyperuricemia
    • Hypochloremic alkalosis
    • Hypokalemia
    • Hypomagnesemia
    • Hyponatremia
    • Increased serum cholesterol
    • Increased serum triglycerides
  • Gastrointestinal:
    • Abdominal cramps
    • Anorexia
    • Constipation
    • Diarrhea
    • Gastric irritation
    • Nausea
    • Pancreatitis
    • Sialadenitis
    • Vomiting
  • Genitourinary:
    • Hematuria
    • Impotence
  • Hematologic & oncologic:
    • Agranulocytosis
    • Aplastic anemia
    • Hemolytic anemia
    • Leukopenia
    • Purpura
    • Thrombocytopenia
  • Hepatic:
    • Jaundice
  • Hypersensitivity:
    • Anaphylaxis
  • Neuromuscular & skeletal:
    • Muscle spasm
    • Systemic lupus erythematosus
    • Weakness
  • Ophthalmic:
    • Blurred vision
    • Xanthopsia
  • Renal:
    • Interstitial nephritis
    • Renal failure
    • Renal insufficiency
  • Respiratory:
    • Pneumonitis
    • Pulmonary edema
    • Respiratory distress
  • Miscellaneous:
    • Fever

Contraindication to chlorothiazide include:

  • Allergy or sensitivity to chlorothiazide, any sulfonamide-derived drug, or any component in the formulation
  • Anuria is a urine volume of less than 100ml within the last 24 hours.

Warnings and Precautions

  • Electrolyte disturbances:
    • It alters blood electrolytes, causing hypercalcemia and hyponatremia as well as hypokalemia, hypochloremic acidosis, hypokalemia, and hypomagnesemia.
  • Orthostatic hypotension
    • This can lead to postural hypotension, especially when combined with concomitant alcohol.
  • Photosensitivity
  • Allergy to sulfonamide ("sulfa drug")
    • Although, the FDA recommends avoiding chlorothiazide in patients allergic to sulfa drugs, however, studies do not indicate any cross-reactivity.
    • Patients with severe reactions should avoid it.
  • Insufficiency of the adrenals:
    • Patients suffering from primary adrenal insufficiency need to avoid chlorothiazide. It may be necessary to adjust the dose of steroid.
  • Diabetes:
    • It may impair glucose metabolism and should be used with caution in patients with diabetes mellitus.
  • Gout
    • It may precipitate gout and should be used with caution in patients with hyperuricemia.
  • Hepatic impairment
    • Patients with liver disease should not take it. Hypokalemia due to excessive chlorothiazide may lead to hepaticencephalopathy.
  • Hypercalcemia:
    • Chlorothiazide should not be used in patients with hypercalcemia.
  • Hypercholesterolemia:
    • This could lead to elevated blood levels, especially of triglyceride.
  • Hypokalemia
    • Before using hypokalemia, it must be corrected
  • Renal impairment
    • Patients with impaired renal function should be cautious.
  • Systemic lupus, erythematosus
    • It could cause SLE due to drug-induced side effects 

Chlorothiazide: Drug Interaction

Note: Drug Interaction Categories:

  • Risk Factor C: Monitor When Using Combination
  • Risk Factor D: Consider Treatment Modification
  • Risk Factor X: Avoid Concomitant Use

Risk Factor C (Monitor therapy).

Ajmaline Sulfonamides can increase the toxic/adverse effects of Ajmaline. Particularly, there may be an increase in the risk of cholestasis.
Alcohol (Ethyl) May increase the orthostatic hypotensive effects of Thiazide or Thiazide-Like Diauretics.
Alfuzosin Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Allopurinol Thiazide or Thiazide-Like Deuretics can increase the risk of hypersensitivity reactions to Allopurinol. Thiazide and Thiazide -Like Diuretics can increase Allopurinol's serum concentration. Thiazide Diuretics, specifically, may increase Oxypurinol's concentration, which is an active metabolite, of Allopurinol.
Aminolevulinic Acid Topical Photosensitizing agents may increase the photosensitizing effects of Aminolevulinic Acid Topical.
Amphetamines May decrease the antihypertensive effects of Antihypertensive Drugs.
Angiotensin-Converting Enzyme Inhibitors Thiazide and Thiazide-Like Diuretics may enhance the hypotensive effect of Angiotensin-Converting Enzyme Inhibitors. Thiazide and Thiazide-Like Diuretics may enhance the nephrotoxic effect of Angiotensin-Converting Enzyme Inhibitors.
Anticholinergic Agents May increase serum Thiazide or Thiazide-Like Diuretics.
Antidiabetic Agents Antidiabetic Agents may be less effective if Thiazide or Thiazide-Like Diauretics are used.
Antidiabetic Agents Hyperglycemia-Associated Agents may diminish the therapeutic effect of Antidiabetic Agents.
Antipsychotic Agents, Second Generation (Atypical) Blood Pressure Lowering Agents can increase the hypotensive effects of Antipsychotic Agents (Second Gen [Atypical]).
Barbiturates May increase the orthostatic hypotensive effects of Thiazide or Thiazide-Like Diauretics.
Barbiturates Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Benperidol Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Beta2-Agonists May increase the hypokalemic effects of Thiazide or Thiazide-Like Diauretics.
Brigatinib May decrease the antihypertensive effects of Antihypertensive Drugs. Brigatinib could increase the bradycardic effects of Antihypertensive Drugs.
Brimonidine (Topical) Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Calcium Salts Thiazide or Thiazide-Like diuretics can decrease calcium salt excretion. Concomitant use may also lead to metabolic alkalosis.
CarBAMazepine Thiazide or Thiazide-Like Dehydrators may increase the toxic/adverse effects of CarBAMazepine. Hyponatremia may be more common.
Cardiac Glycosides Cardiac Glycosides may be more toxic if they are combined with Thiazide or Thiazide-Like diuretics. The hypokalemic or hypomagnesemic effects of thiazide diuretics may increase cardiac glycoside toxicity.
Corticosteroids (Orally inhaled) May increase the hypokalemic effects of Thiazide or ThiazideLike Diuretics.
Corticosteroids (Systemic) May increase the hypokalemic effects of Thiazide or Thiazide-Like Diauretics.
Cyclophosphamide Thiazide or Thiazide-Like Dehydrators may increase Cyclophosphamide's toxic/adverse effects. In particular, granulocytopenia could be increased.
Dexketoprofen May increase the toxic/adverse effects of Sulfonamides.
Dexmethylphenidate Antihypertensive agents may have a less therapeutic effect.
Diacerein Might increase the therapeutic effects of Diuretics. Particularly, there may be an increase in the risk of hypokalemia or dehydration.
Diazoxide Thiazide or Thiazide-Like Diauretics can increase the toxic/adverse effects of Diazoxide.
Diazoxide Might increase the hypotensive effects of Blood Pressure Lowering Agents.
DULoxetine DULoxetine may increase hypotension by lowering blood pressure.
Herbs (Hypertensive Properties) May decrease the antihypertensive effects of Antihypertensive Drugs.
Herbs (Hypotensive properties) Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Hypotension-Associated Agents Blood Pressure Lowering Agents may enhance the hypotensive effect of Hypotension-Associated Agents.
Ipragliflozin Thiazide-Like Diuretics and Thiazide-Like Thiazide may have an adverse/toxic effect. In particular, there may be an increase in the risk of intravascular volume loss.
Ivabradine Thiazide or Thiazide-Like diuretics can increase the arrhythmogenic effects of Ivabradine.
Levodopa-Containing Products Blood Pressure Lowering Agents can increase the hypotensive effects of Levodopa -Containing Products.
Licorice May increase the hypokalemic effects of Thiazide or Thiazide-Like Diauretics.
Lormetazepam Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Methylphenidate May decrease the antihypertensive effects of Antihypertensive Drugs.
Molsidomine Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Multivitamins/Fluoride (with ADE) May increase the hypercalcemic effects of Thiazide or Thiazide-Like Diauretics.
Multivitamins/Minerals (with ADEK, Folate, Iron) Thiazide and Thiazide-Like Diuretics may enhance the hypercalcemic effect of Multivitamins/Minerals (with ADEK, Folate, Iron).
Multivitamins/Minerals (with AE, No Iron) Thiazide and Thiazide-Like Diuretics may increase the serum concentration of Multivitamins/Minerals (with AE, No Iron). Thiazide diuretics can decrease calcium excretion, and prolonged concomitant use may cause metabolic alkalosis.
Naftopidil Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Neuromuscular-Blocking Agents (Nondepolarizing) Thiazide and Thiazide-Like Diuretics may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).
Nicergoline Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Nicorandil Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Nitroprusside The hypotensive effects of Nitroprusside may be enhanced by blood pressure lowering agents.
Nonsteroidal Anti-Inflammatory Drugs Thiazide-Like and Thiazide-Like Diauretics can increase the nephrotoxic effects of Nonsteroidal Anti-Inflammatory agents. Nonsteroidal Anti-InflammatoryAgents may diminish the therapeutic effect of Thiazide and Thiazide-Like Diuretics.
Opioid Agonists Could increase the toxic/adverse effects of Diuretics. The therapeutic effects of Diuretics may be diminished by Opioid Agonists.
Oxcarbazepine Thiazide or Thiazide-Like Dehydrators may increase the toxic/adverse effects of OXcarbazepine. Hyponatremia may be more common.
Pentoxifylline Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Pholcodine Pholcodine may increase hypotensive effects by lowering blood pressure.
Phosphodiesterase 5 Inhibitors Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Porfimer Photosensitizing agents may increase the photosensitizing effects of Porfimer.
Prostacyclin Analogues Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Quinagolide Might increase the hypotensive effects of Blood Pressure Lowering Agents.
Reboxetine May increase the hypokalemic effects of Thiazide or Thiazide-Like Diauretics.
Selective Serotonin Reuptake inhibitors May increase the hyponatremic effects of Thiazide or Thiazide-Like Diauretics.
Toremifene Toremifene's hypercalcemic effects may be enhanced by Thiazide or Thiazide-Like Diauretics.
Verteporfin Photosensitizing agents may increase the photosensitizing effects of Verteporfin.
Vitamin D Analogs Thiazide or Thiazide-Like diuretics can increase the hypercalcemic effects of Vitamin D Analogs.
Yohimbine May decrease the antihypertensive effects of Antihypertensive Drugs.

Risk Factor D (Keep in mind therapy modification)

 
Amifostine Amifostine's hypotensive effects may be enhanced by blood pressure lowering agents. Treatment: Blood pressure lowering drugs should be stopped 24 hours before amifostine administration. Amifostine should be avoided if blood pressure lowering medication cannot be withheld.
Bile Acid Sequestrants This may decrease Thiazide and Thiazide -Like Diuretics absorption. It also decreases the diuretic response.
Dofetilide Thiazide or Thiazide-Like Dehydrators may increase the QTc-prolonging effects of Dofetilide. Thiazide-Like Diuretics and Thiazide Thiazide may increase Dofetilide's serum concentration. Management: Hydrochlorothiazide has been specifically mentioned as a contraindication. However, the risk likely extends all thiazide or thiazide like diuretics. It may also be more dangerous with chlorthalidone and bendroflumethiazide. When possible, consider alternatives.
Lithium Thiazide and Thiazide -Like Diuretics can decrease excretion Lithium.
Obinutuzumab This may increase the hypotensive effects of Blood Pressure Lowering Agents. Management: You may temporarily withhold blood pressure lowering medication beginning 12 hours before obinutuzumab injection and continuing for 1 hour after infusion.
Sodium Phosphates The nephrotoxic effects of Sodium Phosphates may be increased by diuretics. Particularly, acute phosphate-nephropathy (APN) may increase. Management: You can avoid this combination by temporarily stopping treatment with diuretics or looking for alternatives to oral sodium-phosphate bowel preparation. Hydrate well and monitor your renal and fluid status if the combination is not possible.
Topiramate Thiazide or Thiazide-Like Deuretics can increase the hypokalemic effects of Topiramate. Thiazide-Like and Thiazide Diuretics can increase serum Topiramate concentrations. Monitoring: Watch for elevated topiramate levels/adverse reactions (e.g. hypokalemia) when a thiazide-like diuretic is being initiated or increased in dose. Monitor serum potassium levels closely when concomitant therapy is being administered. It may be necessary to reduce the dose of Topiramate.

Risk Factor X (Avoid Combination)

 
Aminolevulinic Acid Systemic The photosensitizing effects of Aminolevulinic Acid Systemic may be enhanced by the use of photosensitizing agents.
Bromperidol Bromperidol's hypotensive effects may be enhanced by Blood Pressure Lowering agents. Bromperidol could decrease the hypotensive effects of Blood Pressure Lowering agents.
Levosulpiride Thiazide or Thiazide-Like diuretics can increase the toxic/adverse effects of Levosulpiride.
Mecamylamine Sulfonamides can increase the toxic/adverse effects of Mecamylamine.
Promazine Thiazide or Thiazide-Like diuretics can increase the QTc-prolonging effects of Promazine.

Monitoring Parameters:

  • Serum electrolytes,
  • renal function,
  • blood pressure;
  • assess weight,
  • intake and output reports daily to determine fluid loss

How to Administer Chlorothiazide?

  • Administer the drug as an intravenous infusion.
  • It should not be administered via intramuscular or SubQ route.
  • Extravasation of the drug must be avoided.

Mechanism of action of Chlorothiazide:

  • It acts by blocking the reabsorption sodium and chloride from the distal tubules, resulting in their expulsion along with water. 
  • It is possible to also lose potassium, hydrogen ions and magnesium.

TheStart of action The oral tablet takes approximately 2 hours, while the intravenous formulation takes about 15 minutes.

For the oral drug to reach its peak, it can take up to 4 hours while for the IV drug, it can take just 15 minutes.

The oral drug's duration of action isIt can take between 6 and 12 hours for intraveneous forms, while it takes about 3 hours. 

It is not metabolized and poorly absorbed. 

Its bioavailability ranges from 9% to 56%.

Half-life is the time it takes to get rid of the drug.

It is excreted mostly via urine.

International Brands of Chlorothiazide:

  • Azide
  • Chlorosal
  • Chlotride
  • Disalunil
  • Diurilix
  • Diurone
  • Diurosulfona
  • Hydrochlorothiazidum
  • Niagar
  • Saluretil
  • Saluric
  • Salutrid
  • Urinex

Chlorothiazide Brands in Pakistan:

No brands available in Pakistan

Comments

NO Comments Found